Proceedings of a consensus development conference on standardized measures in diabetic neuropathy
1992; Wiley; Volume: 15; Issue: 10 Linguagem: Inglês
10.1002/mus.880151014
ISSN1097-4598
Autores Tópico(s)Parkinson's Disease Mechanisms and Treatments
ResumoMuscle & NerveVolume 15, Issue 10 p. 1143-1170 Article Proceedings of a consensus development conference on standardized measures in diabetic neuropathy Dr. Richard Kahn, Corresponding Author Dr. Richard Kahn American Diabetes Association, 1660 Duke Street, Alexandria, VA 22314American Diabetes Association, 1660 Duke Street, Alexandria, VA 22314Search for more papers by this author Dr. Richard Kahn, Corresponding Author Dr. Richard Kahn American Diabetes Association, 1660 Duke Street, Alexandria, VA 22314American Diabetes Association, 1660 Duke Street, Alexandria, VA 22314Search for more papers by this author First published: October 1992 https://doi.org/10.1002/mus.880151014Citations: 18Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL References 1 Report and Recommendations of the San Antonio Conference on Diabetic Neuropathy. Diabetes 37: 1000– 1004, 1988 References 1 Dyck PJ, Kratz KM, Lehman KA, Karnes JL, Melton LJ, O'Brien PC, Litchy WJ, Windebank AJ, Smith BE, Low PA, Service FJ, Rizza RA, Zimmerman BA: The Rochester Diabetic Neuropathy Study: design, criteria for types of neuropathy, selection bias, and reproducibility of neuropathic tests. Neurology 41: 799– 807, 1991 2 Dyck PJ, Karnes J, O'Brien PC, Swanson CJ: Neuropathy symptom profile in health, motor neuron disease, diabetic neuropathy, and amyloidosis. Neurology 36: 1300– 308, 1986 3 Report and recommendations of the San Antonio Conference on Diabetic Neuropathy. Neurology 38: 1161– 65, 1988 4 Britland ST, Young RJ, Sharma AK, Clarke BF: Association of painful and painless diabetic polyneuropathy with different patterns of nerve fiber degeneration and regeneration. Diabetes 39: 898– 908, 1990 5 Gracely RH, McGrath P, Dubner R: Validity and sensitivity of sensory and affective verbal pain descriptors: manipulation of affect by diazepam. Pain 5: 19– 29, 1978 6 Max MB, Culnane M, Schafer SC, Gracely H, Walther DJ, Smoller B, Dubner R: Amitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood. Neurology 37: 589– 96, 1987 7 Guy RJC, Gilbey SC, Sheehy M, Asselman P, Watkins PJ: Diabetic neuropathy in the upper limb and the effect of 12 months Sorbinol treatment. Diabetologia 31: 214– 20, 1988 8 Archer AG, Watkins PJ, Thomas PK, Sharma K, Payen J: The natural history of acute painful neuropathy in diabetes mellitus. J Neurol Neurosurg Psychiatry 46: 491– 99, 1983 References 1 Sima AAF, Bril V, Nathaniel V, McEwen TA, Brown M, Lattimer SA, Greene DA: N Engl J Med 319: 548– 55, 1988 2 Sima AAF, Brown MB, Prashar A, Chakrabarti C, Laudadio C, Greene DA: The reproducibility and sensitivity of sural nerve morphometry in the assessment of diabetic peripheral polyneuropathy. Diabetologia. In press 3 Greene DA, Yagihashi S, Lattimer SA, Sima AAF: Nerve Na+-K+-ATPase, conduction and myo inositol in the insulin deficient BB rat. Am J Physiol 247: E534– 39, 1984 4 Greene DA, Lattimer SA, Sima AAF: Sorbitol, myo inositol and sodium potassium ATPase in the pathogenesis of diabetic complications. N Engl J Med 316: 599– 606, 1987 5 Sima AAF, Nathaniel V, Bril V: Histopathological heterogeneity of neuropathy in insulin-dependent and non-insulin-dependent diabetes, and demonstration of axo-glial dysjunction in human diabetic neuropathy. J Clin Invest 81: 349– 64, 1988 6 Dyck PJ, Karnes J, Lais A: Pathologic alterations of the peripheral nervous system of humans. In Peripheral Neuropathy. 2nd Ed. PJ Dyck, PK Thomas, EH Lambert, R Bunge, Eds. Philadelphia, PA, Saunders, 1984, p. 760 7 Dyck PJ, Lais A, Karnes JL: Fiber loss is primary and multifocal in sural nerves in diabetic polyneuropathy. Ann Neurol 19: 425– 39, 1986 8 Johnson PC, Doll SC, Cromey DW: Pathogenesis of diabetic neuropathy. Ann Neurol 19: 450– 57, 1986 9 Sima AAF, Nathaniel V, Prashar A: Endoneurial microvessels in human diabetic neuropathy: endothelial cell dysjunction and lack of treatment effect by aldose reductase inhibitor. Diabetes 40: 1090– 100, 1991 10 Pollock M, Nukada H, Taylor P, Donaldson I, Carroll G: Comparison between fascicular and whole sural nerve biopsy. Ann Neurol 13: 65– 68, 1983 11 Levy DM, Karanth SS, Springall DR, Polak JM: Depletion of cutaneous nerves and neuropeptides in diabetes mellitus: an immunocytochemical study. Diabetologia 32: 427– 33, 1989 12 Lindberger M, Daa Schroeder H, Schutlzberg M, Kristensson K, Persson A, Oestman J, Lind H: Nerve fiber studies in skin biopsies in peripheral neuropathies. I. Immunohistochemical analysis of neuroptides in diabetes mellitus. J Neurol Sci 93: 289– 96, 1989 13 Johnson PC, Doll SC: Dermal nerves in human diabetic subjects. Diabetes 33: 244– 50, 1984 14 Beggs JL, Johnson PC, Olafsen AG, Cleary CP, Watkins CJ, Targovnik JH, Koep LJ: Signs of nerve regeneration and repair following pancreas transplantation in an insulin-dependent diabetic with neuropathy. Clin Transplant 4: 133– 41, 1990 References 1 Report and recommendations of the San Antonio Conference on Diabetic Neuropathy. Diabetes 37: 259– 65, 1988 2 Daube JR: Electrophysiologic testing in diabetic neuropathy. In Diabetic Neuropathy. PJ Dyck, PK Thomas, A Asbury, A Winegrad, D Porte, Eds. Philadelphia, PA, Saunders, 1987, p. 162– 76 3 Dyck PG, Kratz KM, Lehman RA, Karnes JL, Melton LJ, O'Brien PC, Litchy WJ, Windebank AJ, Smith BE, Low PA, Service FJ, Rizza RA, Zimmerman BR: The Rochester Diabetic Neuropathy Study: design, criteria for types of neuropathy, selection bias, and reproducibility of neuropathic test. Neurology 41: 799– 807, 1991 4 Wilbourn AJ: The diabetic neuropathies. In Clinical Electromyography. W Brown, C Bolton, Eds. New York, Butterworths, 1985, p. 329– 62 5 Kimura J: Electrodiagnosis in Diseases of Nerve and Muscle. Ed. 2. Philadelphia, PA, Davis, 1989 6 Denys EH: AAEM Minimonegraph 14. The Influence of Temperature in Clinical Neurophysiology. Muscle Nerve 14: 795– 851, 1991 7 Dyck PJ, Karnes JL, O'Brien PC, Litchy WJ, Low PA, Melton LJ: The Rochester Diabetic Neuropathy Study: reassessment of tests and criteria for diagnosis and staged severity. Neurology. In press 8 Behse F, Buchtal F, Carlsen F: Nerve biopsy and conduction studies in diabetic neuropathy. J Neurol Neurosurg Psychiatry 40: 1072– 82, 1977 9 Dyck PJ, Karnes JL, Daube JR, O'Brien PJ, Service FJ: Clinical and neuropathologic criteria for the diagnosis and staging of the diagnosis and staging of diabetic polyneuropathy. Brain 108: 861– 80, 1985 10 The DCCT Research Group: Factors in the development of diabetic neuropathy: baseline analysis of neuropathy in the feasibility phase of the Diabetes Control and Complications Trial (DCCT). Diabetes 37: 476– 81, 1988 11 Mulder DW, Lambert EH, Bastron JA, Sprague RG: The neuropathies associated with diabetes mellitus: a clinical and electromyographic study of 103 unselected diabetic patients. Neurology 11: 275– 84, 1961 12 Chaudry V, Cornblath DR, Mellits Ed, Avila O, Freimer ML, Glass JD, Reim J, Ronnett GV, Quaskey SA, Kuncl RW: Inter- and intra-examiner reliability of nerve conduction measurements in normal subjects. Ann Neurol 30: 841– 43, 1991 13 Dyck PJ, Karnes J, O'Brien PC: Diagnosis, staging and classification of diabetic neuropathy and associations with other complications. In Diabetic Neuropathy. PJ Dyck, PK Thomas, A Asbury, A Winegrad, A Porte, Eds. Philadelphia, PA, Saunders, 1987, p. 36– 44 14 Brismar T, Sima AAF: Changes in nodal function in nerve in nerve fibers of the spontaneously diabetic BB Wistar rat: potential clamp analysis. Acta Physiol Scand 113: 499– 510, 1981 References 1 Schwartz NS, Clutter WE, Shan SD, Cryer PE: The glycemic thresholds for activation of glucose counterregulatory systems are higher than the threshold for symptoms. J Clin Invest 79: 777– 81, 1987 2 Mitrakou A, Ryan C, Veneman T, Mokan M, Jennssen T, Kiss I, Durrant J, Cryer P, Gerich J: Hierarchy of glycemic thresholds for counterregulatory hormone secretion, symptoms, and cerebral dysfunction. Am J Physiol 260: E67– 74, 1991 3 Achem-Karam SR, Funakoshi A, Vinik AI: Plasma motilin and migrating motor complex in diabetic gastroparesis. Gastroenterology 88: 492– 94, 1985 4 Genovely H, Pfeifer MA: RR-Variation: the autonomic test of choice in diabetes. Diabetes Metab Rev 4: 255– 71, 1988 5 Pfeifer MA, Cook D, Brodsky J, Tice D, Reenan A, Swedine S, Halter JB, Porte Jr D: Quantitative evaluation of cardiac parasympathetic activity in normal and diabetic man. Diabetes 31: 339– 45, 1982 6 Weinberg CR, Pfeifer MA: Development of a predictive model for symptomatic neuropathy in diabetes. Diabetes 35: 873– 80, 1986 7 Pfeifer MA, Halter JB, Weinber CR, Cook D, Best J, Reenan A, Porte, D Jr: Differential changes of autonomic nervous system function with age in man. Am J Med 75: 249, 1983 8 Ewing DJ, Campbell IW, Clarke BF: Heart rate changes in diabetes mellitus. Lancet 1: 183, 1981 9 Pfeifer MA, Weinberg CR, Cook D, Reenan A, Halter JB, Ensinck J, Porte, Jr D: Autonomic neural dysfunction in recently diagnosed diabetic subjects. Diabetes Care 7: 447– 53, 1984 10 Rothschild AH, Weinberg C, Cook D, Halter J, Porte D, Pfeifer MA: Sensitivity of R-R variation and the Valsalva ratio in the assessment of cardiovascular diabetic autonomic neuropathy. Diabetes Care 40: 735– 41, 1987 11 Sandroin P, Benarroch EE, Low PA: Pharmacologic dissection of the components of the valsalva maneuver in adrenergic failure. J Appl Physiol 71: 1563– 67, 1991 12 Kahn JK, Sisson JC, Vinik AI: QT Interval prolongation and sudden cardiac death in diabetic autonomic neuropathy. J Clin Endocrinol Metab 64: 751– 54, 1987 13 Gonin JM, Kadrofske MM, Schmaltz S, Vinik AI: Corrected Q-T interval prolongation as diagnostic tool for assessment of cardiac autonomic neuropathy in diabetes mellitus. Diabetes Care 13: 68– 71, 1990 14 Pfeifer MA, Code DL, Brodsky J: Quantitative evaluation of sympathetic and parasympathetic control of iris function. Diabetes Care 5: 518– 28, 1982 15 Barnett JL, Vinik AI: Gastointestinal disturbances in diabetes. In Therapy for Diabetes Mellitus and Related Disorders. AE Lebovitz, Ed. Alexandria, VA, Am. Diabetes Assoc., 1991, p. 279– 87 16 Karacan I, Salis PJ, Ware JC, Derveut B, Williams RL, Scott FB, Attia SL, Beutler LE: Nocturnal penile tumescence and diagnosis in diabetic impotence. Am J Psychiatry 135: 191– 97, 1978 17 Krane RJ, Goldstein I, Saenz de Tejada I: Impotence. N Engl J Med 321: 1648– 59, 1989 18 Sarica Y, Karacan I: Bulbocavernosus reflex to somatic and visceral nerve stimulation in normal subjects and in diabetics with erectile impotence. J Urol 138: 55– 58, 1987 19 Fridmodt-Moller C: Diabetic cystopathy. Danish Med Bull 25: 49– 59, 1978 20 Bradley WE: Diagnosis of urinary bladder dysfunction in diabetes mellitus. Ann Intern Med 92: 323– 26, 1980 21 Lapides J: Denervation supersensitivity as a test for neurogenic bladder. Surg Gynecol Obstet 114: 241– 49, 1962 22 Fealey RD, Low PA, Thomas JE: Themoregulatory sweating abnormalities in diabetes mellitus. Mayo Clin Proc 64: 617– 28, 1989 23 Shahani BT, Halperin JJ, Boulu P, Cohen J: Sympathetic skin response: a method of assessing unmyelinated axon dysfunction in peripheral neuropathies. J Neural Neurosurg Psychiat 47: 536– 42, 1984 24 Kennedy WR, Sakuta M, Sutherland D, Goetz FC: Quantitation of the sweating deficit in diabetes mellitus. Ann Neurol 15: 482– 88, 1984 25 Low PA, Zimmerman BR, Dyck PJ: Comparison of distal sympathetic with vagal function in diabetic neuropathy. Muscle Nerve 9: 592– 96, 1986 26 Low PA, Caskey PE, Tue RR, Fealey RD, Dyck PJ: Quantitive sudomotor axon reflex test in normal and neuropathic subjects. Ann Neurol 14: 573– 80, 1983 27 Cryer PE: Iatrogenic hypoglycemia as a cause of hypoglycemia-associated autonomic failure in IDDM: a vicious cycle. Diabetes 41: 255– 60, 1992 28 Diabetes Control and Complications Trial Research Group: Epidemiology of severe hypoglycemia in the diabetes control and complications trial. Am J Med 90: 450– 59, 1991 29 Bjork E, Palmer M, Schvarcz E, Berne C: Incidence of severe hypoglycemia in an unselcted population of patients with insulin-treated diabetes mellitus with special refernce to autonomic neuropathy. Diabetes Nutr Metab 4: 303– 309, 1990 30 Heller SR, Cryer PE: Reduced neuroendocrine and symptomatic responses to subsequent hypoglycemia after one episode of hypoglycemia in nondiabetic humans. Diabetes 40: 223– 26, 1991 31 Widom B, Simonson DC: Effect of intermittent hypoglycaemia on counterregulatory hormone secretion (Abstract). Diabetologia 33: A484, 1990 32 Davis M, Shamoon H: Adaptive counterregulatory responses to hypogycemia in nondiabetic humans (Abstract). Diabetes 38: 5A, 1989 33 White NH, Skor DA, Cryer PE, Bier DM, Levandoski L, Santiago JV: Identification of type I diabetic patients at increased risk for hypoglycemia during intensive therapy. N Engl J Med 308: 485– 91, 1983 34 Bolli GB, Defeo P, DeCosmo S, Perriello G, Ventura MM, Massi-Benedetti M, Santeusanio F, Gerich JE, Brunetti P: A reliable and reproducible test for adequate glucose counterregulation in type I diabetes mellitus. Diabetes 33: 732– 37, 1984 35 Boyle PJ, Schwartz NS, Shah SD, Clutter WE, Cryer PE: Plasma glucose concentrations at the onset of hypoglycemic symptoms in patients with poorly controlled diabetes and in nondiabetics. N Engl J Med 318: 1487– 92, 1988 36 Hirsch IB, Boyle PJ, Draft S, Cryer PE: Higher glycemic thresholds for symptoms during beta-adrenergic blockade in IDDM. Diabetes 40: 1177– 86, 1991 Citing Literature Volume15, Issue10October 1992Pages 1143-1170 ReferencesRelatedInformation
Referência(s)